Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium

Thrombosis Research

Volumn 11, Issue 3, 1977, Pages 323-344

  Moncada, S ^a   Herman, A G ^a   Higgs, E A ^a   Vane, J R ^a  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN;

BLOOD VESSEL WALL; IN VITRO STUDY; THROMBOSIS;

ANIMAL; AORTA, THORACIC; ARACHIDONIC ACIDS; ENDOTHELIUM; EPOPROSTENOL; FIBRINOLYTIC AGENTS; INDOMETHACIN; PLATELET AGGREGATION; PROSTAGLANDINS; PROSTAGLANDINS H; RABBITS;

EID: 0017749182     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(77)90185-2     Document Type: Article

References (54)

1. The fine structure of experimental thrombi
2. The structure of haemostatic plugs and experimental thrombi in small arteries
3. Role of platelets in thrombosis
4. Experimental platelet thrombus
5. Vascular endothelial damage and thrombosis
6. Vascular endothelium and thrombogenesis
7. The subendothelium and thrombogenesis
8. The ultrastructure of initial stages of platelet aggregation and adhesion to damaged vessel walls in vivo
9. The role of the endothelium in the initial phases of thrombosis
10. Platelets in hemostasis and thrombosis
11. Platelet interaction with vascular structures
12. Platelet aggregation at site of minimal endothelial injury
13. The ultrastructure of early platelet aggregation in vivo
14. Platelet adhesion in the rabbit abdominal aorta following the removal of the endothelium: a scanning and transmission electron microscopical study
15. The vascular wall in the pathogenesis of thrombosis
16. The adhesiveness of native platelets and its prevention
17. The role of the endothelium in the resolution of a thrombus
18. Drugs that affect platelet behaviour
19. Prostaglandins and platelet function
20. The inhibition of platelet aggregation by an aorta intima extract
21. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
22. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
23. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
24. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
25. Human arterial and venous tissues generate prostacyclin (Prostaglandin X), a potent inhibitor of platelet aggregation
26. A new prostaglandin metabolite of arachidonic acid
27. The chemical characterization of prostaglandin X (prostacyclin)
28. Protein measurement with the Folin phenol reagent
29. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation
30. On the specificity of oxygenation of unsaturated fatty acids catalysed by soyabean lipoxygenase
31. Relations of abnormal and injury electric potential differences to intravascular thrombosis
32. Thromboplastic and fibrinolytic activity of the human aorta
33. Tissue activators of plasminogen
34. The regeneration of aortic endothelium
35. Eine neue Methode zur Erzeugung von Thromben durch gezielte Überdenhnung der Gefässwand
36. Vascular intimal components: precursors of thrombosis
37. Tissue specific induction of platelet aggregation in vitro
38. The release of prostaglandins from lung and other tissues
39. Circulating endothelial cells in endotoxin-treated rabbit
40. The alterations of venous endothelium in experimental thrombosis produced by catecholamines and metals
41. Accolement des plaquettes au collagene
42. Nouvelles recherches sur l'accolement des plaquettes aux fibres de collagene
43. Transmedial collagen and elastin gradients in human aortas: reversal with age
44. Response of platelets to tissue injury
45. Ultrastructure and behaviour of platelet thrombi in injured arteries
46. Platelet aggregation induced by basement membranes
47. The relationship between the structure of a thrombus or a hemostatic plug and the mechanisms involved in its formation
48. The platelet contribution to arterial and venous thrombosis
49. Salicylates and bleeding: the aspirin tolerance test
50. An endoperoxide aggregator (LASS) formed in platelets in response to thrombotic stimuli
51. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides
52. The effect of inhibition of prostaglandin synthesis on microvascular haemostasis and macromolecular leakage
53. The effect of aspirin on in vivo platelet function in humans